Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)

China flag China · Delayed Price · Currency is CNY
22.89
+0.29 (1.28%)
At close: Apr 29, 2026
-11.69%
Market Cap 4.35B
Revenue (ttm) 1.55B
Net Income (ttm) 165.20M
Shares Out 190.18M
EPS (ttm) 0.87
PE Ratio 26.31
Forward PE n/a
Dividend 0.50 (2.21%)
Ex-Dividend Date Nov 28, 2025
Volume 1,417,100
Average Volume 2,047,498
Open 22.59
Previous Close 22.60
Day's Range 22.46 - 23.04
52-Week Range 21.46 - 41.47
Beta 0.16
RSI 38.29
Earnings Date Apr 28, 2026

About SHE:003020

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA. It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlor... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 1,456
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 003020
Full Company Profile

Financial Performance

In 2025, SHE:003020's revenue was 1.55 billion, an increase of 2.33% compared to the previous year's 1.52 billion. Earnings were 165.20 million, an increase of 2.86%.

Financial Statements

News

There is no news available yet.